Skip to main content

Cyclophosphamide News

Genmab Announces U.S. FDA Approval of Arzerra (ofatumumab) in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL

Copenhagen, Denmark; August 31, 2016 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Multiple Sclerosis, Prostate Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Multiple Myeloma, Breast Cancer, view more... Cancer, Chronic Lymphocytic Leukemia (CLL), Chronic Myelogenous Leukemia (CML), Diffuse Large B-Cell Lymphoma, Endometrial Cancer, Systemic Lupus Erythematosus

Cyclophosphamide patient information at Drugs.com